Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$690K Buy
18,800
+7,700
+69% +$311K 0.01% 1413
2017
Q2
$504K Buy
11,100
+4,900
+79% +$216K 0.01% 1601
2017
Q1
$264K Buy
+6,200
New +$253K 0.01% 1723
2016
Q3
Sell
-300
Closed -$10K 3253
2016
Q2
$10K Buy
+300
New +$10.4K ﹤0.01% 3077
2015
Q4
Sell
-1,400
Closed -$55K 3804
2015
Q3
$55K Buy
1,400
+1,300
+1,300% +$51.6K ﹤0.01% 3258
2015
Q2
$4K Buy
+100
New +$3.5K ﹤0.01% 3669
2014
Q2
Sell
-41,700
Closed -$897K 4655
2014
Q1
$897K Buy
41,700
+13,200
+46% +$285K 0.01% 2105
2013
Q4
$637K Sell
28,500
-56,100
-66% -$1.24M ﹤0.01% 2301
2013
Q3
$1.75M Buy
84,600
+66,100
+357% +$1.41M 0.01% 1485
2013
Q2
$357K Buy
+18,500
New +$386K ﹤0.01% 2656

Other funds holding HOLX

Spot Trading's HOLX Position: Q3 2017 in Review

Spot Trading sold out of Hologic (HOLX) in Q3 2017, closing a stake of 9,379 shares — an estimated $379K sold.

Spot Trading first reported a position in HOLX in Q1 2014 and held it in 12 quarters. The position peaked at $4.04M in Q2 2015. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Spot Trading reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 9,379 Hologic shares in Q3 2017, an estimated $379K.
  • Spot Trading first reported a position in Hologic in Q1 2014 and held it in 12 quarters.
  • Spot Trading's Hologic position peaked at $4.04M in Q2 2015.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.